Cargando…

Rituximab-based combination therapy in patients with Waldenström macroglobulinemia: a systematic review and meta-analysis

BACKGROUND: To evaluate the efficacy and safety of rituximab-based combination therapy for Waldenström macroglobulinemia (WM), we conducted this meta-analysis by pooling the rates of overall response, major response, complete response, and grade ≥3 hematological adverse events. METHODS AND MATERIALS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yan-Hua, Xu, Li, Cao, Chun, Feng, Juan, Tang, Hai-Long, Shu, Mi-Mi, Gao, Guang-Xun, Chen, Xie-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469478/
https://www.ncbi.nlm.nih.gov/pubmed/31043792
http://dx.doi.org/10.2147/OTT.S191179